Literature DB >> 19166888

CpG oligonucleotides as immunotherapeutic adjuvants: innovative applications and delivery strategies.

Aliasger K Salem, George J Weiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19166888      PMCID： PMC2667912          DOI： 10.1016/j.addr.2008.12.003

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


× No keyword cloud information.
  28 in total

1.  Cationic microparticles: A potent delivery system for DNA vaccines.

Authors:  M Singh; M Briones; G Ott; D O'Hagan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 2.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 3.  CpG motifs: the active ingredient in bacterial extracts?

Authors:  Arthur M Krieg
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

4.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

Authors:  D M Klinman; A K Yi; S L Beaucage; J Conover; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

5.  IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides.

Authors:  A K Yi; J H Chace; J S Cowdery; A M Krieg
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

6.  CpG motifs in bacterial DNA trigger direct B-cell activation.

Authors:  A M Krieg; A K Yi; S Matson; T J Waldschmidt; G A Bishop; R Teasdale; G A Koretzky; D M Klinman
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

7.  Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

Authors:  Jörg Vollmer; Risini Weeratna; Paul Payette; Marion Jurk; Christian Schetter; Meike Laucht; Tanja Wader; Sibylle Tluk; Ming Liu; Heather L Davis; Arthur M Krieg
Journal:  Eur J Immunol       Date:  2004-01       Impact factor: 5.532

8.  Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha.

Authors:  M D Halpern; R J Kurlander; D S Pisetsky
Journal:  Cell Immunol       Date:  1996-01-10       Impact factor: 4.868

9.  CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.

Authors:  Anthony D Sandler; Hiroshi Chihara; Gen Kobayashi; Xiaoyan Zhu; Michal A Miller; David L Scott; Arthur M Krieg
Journal:  Cancer Res       Date:  2003-01-15       Impact factor: 12.701

10.  Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.

Authors:  George Mutwiri; Ponn Benjamin; Henry Soita; Lorne A Babiuk
Journal:  Vaccine       Date:  2008-04-03       Impact factor: 3.641
View more
  9 in total

1.  CpG adjuvant enhances the mucosal immunogenicity and efficacy of a Treponema pallidum DNA vaccine in rabbits.

Authors:  Feijun Zhao; Shuangquan Liu; Xiaohong Zhang; Jian Yu; Tiebing Zeng; Weiming Gu; Xunyu Cao; Xi Chen; Yimou Wu
Journal:  Hum Vaccin Immunother       Date:  2013-04-01       Impact factor: 3.452

2.  Bacterial 'immunity' against bacteriophages.

Authors:  Stephen T Abedon
Journal:  Bacteriophage       Date:  2012-01-01

3.  Adjuvants for Leishmania vaccines: from models to clinical application.

Authors:  Vanitha S Raman; Malcolm S Duthie; Christopher B Fox; Greg Matlashewski; Steven G Reed
Journal:  Front Immunol       Date:  2012-06-11       Impact factor: 7.561

4.  Development of CpG-oligodeoxynucleotides for effective activation of rabbit TLR9 mediated immune responses.

Authors:  Tsung-Hsien Chuang; Chao-Yang Lai; Ping-Hui Tseng; Chiun-Jye Yuan; Li-Chung Hsu
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 5.  Progress of Phototherapy Applications in the Treatment of Bone Cancer.

Authors:  Jiachen Sun; Fei Xing; Joy Braun; Frank Traub; Pol Maria Rommens; Zhou Xiang; Ulrike Ritz
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

6.  Effect of molecular weight of polyethyleneimine on loading of CpG oligodeoxynucleotides onto flake-shell silica nanoparticles for enhanced TLR9-mediated induction of interferon-α.

Authors:  Yuvaraj Manoharan; Qingmin Ji; Tomohiko Yamazaki; Shanmugavel Chinnathambi; Song Chen; Singaravelu Ganesan; Jonathan P Hill; Katsuhiko Ariga; Nobutaka Hanagata
Journal:  Int J Nanomedicine       Date:  2012-07-16

Review 7.  Applying biodegradable particles to enhance cancer vaccine efficacy.

Authors:  Kawther K Ahmed; Sean M Geary; Aliasger K Salem
Journal:  Immunol Res       Date:  2014-08       Impact factor: 4.505

8.  pUC18-CpG Is an Effective Adjuvant for a Duck Tembusu Virus Inactivated Vaccine.

Authors:  Xiao Ren; Xiaolei Wang; Shan Zhang; Xintao Gao; Lichun Fang; Xixi Wang; Weidong Lin; Hong Jia; Xiaoyu Guo; Ting Xin; Hongfei Zhu; Jian Lin; Shaohua Hou
Journal:  Viruses       Date:  2020-02-20       Impact factor: 5.048

Review 9.  Activation of Innate Immunity by Therapeutic Nucleic Acids.

Authors:  Ali Bishani; Elena L Chernolovskaya
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.